Peripheral T-cell lymphoma following rituximab therapy for B-cell lymphoma [6]

Blood

Volumn 93, Issue 7, 1999, Pages 2427-2428

  Micallef, I N M ^a   Kirk, A ^a   Norton, A ^a   Foran, J M ^a   Rohatiner, A Z S ^a   Lister, T A ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIBODY; CD2 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHIMERIC ANTIBODY; IMMUNOGLOBULIN A; RITUXIMAB; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ADULT; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; B CELL LYMPHOMA; CASE REPORT; CERVICAL LYMPH NODE; CLINICAL TRIAL; COMPLEMENT DEPENDENT CYTOTOXICITY; EXCISION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; LETTER; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; PRIORITY JOURNAL; T CELL LYMPHOMA;

EID: 0033120369     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.7.2427     Document Type: Letter

References (6)